Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

被引:58
|
作者
Zenner, HP
Baumgarten, C
Rasp, G
Fuchs, T
Kunkel, G
Hauswald, B
Ring, J
Effendy, I
Behrendt, W
Frosch, PJ
Przybilla, B
Brunner, FX
Merk, HF
Kapp, A
Schnitker, J
Wolf, H
机构
[1] SCHERAX ARZNEIMITTEL GMBH,D-22589 HAMBURG,GERMANY
[2] UNIV TUBINGEN,HNO KLIN,TUBINGEN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,ABT KLIN IMMUNOL & ASTHMAPOLIKLIN,D-1000 BERLIN,GERMANY
[4] MAXIMILIANS UNIV,KLINIKUM GROSSHADERN,HNO KLIN & POLIKLIN,MUNICH,GERMANY
[5] UNIV GOTTINGEN,HAUTKLIN,D-3400 GOTTINGEN,GERMANY
[6] MED ACAD CARL GUSTAV CARUS,HNO KLIN,DRESDEN,GERMANY
[7] TECH UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-8000 MUNICH,GERMANY
[8] KLINIKUM PHILIPPS UNIV,MED ZENTRUM HAUTKRANKHEITEN,MARBURG,GERMANY
[9] UNIV LEIPZIG,HNO KLIN,D-7010 LEIPZIG,GERMANY
[10] UNIV WITTEN HERDECKE,WITTEN,GERMANY
[11] STADT KLINIKEN,HAUTKLIN,DORTMUND,GERMANY
[12] UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-80539 MUNICH,GERMANY
[13] UNIV WURZBURG,HNO KLIN & POLIKLIN,WURZBURG,GERMANY
[14] RHEIN WESTFAL TH AACHEN,HAUTKLIN,D-5100 AACHEN,GERMANY
[15] HANNOVER MED SCH,DERMATOL KLIN & POLIKLIN,HANNOVER,GERMANY
[16] INST ANGEW STAT,BIELEFELD,GERMANY
关键词
short-term immunotherapy; specific immunotherapy; allergic rhinitis; grass pollen; rye pollen; skin prick rest; specific IgE; specific IgG4;
D O I
10.1016/S0091-6749(97)70190-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short-term immunotherapy (STI) can be beneficial for patients who are noncompliant,vith long-term specific immunotherapy. Objective: The efficacy and tolerance of STI with seven pre-seasonal injections of molecular standardized allergens from grass and rye pollen has been investigated in a double-blind, placebo-controlled multicenter study with 87 patients at 12 German University hospitals. Methods: Symptoms of the eyes, nose, and bronchi and use of symptomatic drugs were documented daily in diaries by patients with allergic rhinitis to grass and/or rye pollen and without bronchial asthma. Patients were monitored by skin prick test titration and measurement of levels of specific IgE and IgG4. Results: The median nasal score for the 10 weeks with the strongest symptoms during the gross pollen season was significantly lower (p = 0.014) with 35.0 for STI (n = 41) versus 69.0 for placebo (n = 40); the overall symptom score was 54.0 for STI versus 97.5 for placebo (p = 0.020). Only STI-treated patients exposed to less than 40 pollen grains per cubic meter per week showed a significantly lower nasal symptom score of 39.0 versus 75.0 for placebo (p = 0.006); these patients also had fewer nasal symptoms and less use of topical nasal drugs (p < 0.001). The threshold dose in skin prick tests was significantly higher, being 9.06 histamine equivalent for skin prick test (HEP) for STI-treated patients who received the maximum dose (n = 22) versus 4.33 HEP for placebo (p = 0.005). Specific IgE levels were significantly higher, being 55.9 SU/ml for STI versus 393 SU/ml for placebo after seven injections (p = 0.006) and level of specific IgG4 was 5.36% for STI versus 1.28% for placebo (p < 0.001). No severe systemic reactions were observed. Conclusion: Sn with seven preseasonal injections with molecular standardized allergens is effective and well tolerated.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually
    Panzner, P.
    Petras, M.
    Sykora, T.
    Lesna, I.
    RESPIRATORY MEDICINE, 2008, 102 (09) : 1296 - 1304
  • [42] Pollen low dose intradermal therapy evaluation (PollenLITE): a double-blind randomised placebo-controlled trial of low-dose intradermal grass pollen immunotherapy in seasonal allergic rhinitis
    Slovick, A.
    Douiri, A.
    Muir, R.
    Guerra, A.
    Tsioulos, K.
    Hay, E.
    Emily, L.
    Kelly, J.
    Peacock, J.
    Ying, S.
    Mohamed, S.
    Cousins, D.
    Durham, S.
    Till, S.
    ALLERGY, 2016, 71 : 60 - 60
  • [43] Specific immunotherapy with a standardized latex extract in allergic workers:: A double-blind, placebo-controlled study
    Sastre, J
    Fernández-Nieto, M
    Rico, P
    Martín, S
    Barber, D
    Cuesta, J
    Heras, MD
    Quirce, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (05) : 985 - 994
  • [44] Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: An analysis of randomized, prospective, single- or double-blind, placebo-controlled studies
    Ross, RN
    Nelson, HS
    Finegold, I
    CLINICAL THERAPEUTICS, 2000, 22 (03) : 342 - 350
  • [45] House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis
    Bozek, A.
    Ignasiak, B.
    Filipowska, B.
    Jarzab, J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (02): : 242 - 248
  • [46] DIFFERENCES IN CLINICAL AND IMMUNOLOGICAL REACTIVITY OF PATIENTS ALLERGIC TO GRASS POLLENS AND TO MULTIPLE-POLLEN SPECIES .2. EFFICACY OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, SPECIFIC IMMUNOTHERAPY WITH STANDARDIZED EXTRACTS
    BOUSQUET, J
    BECKER, WM
    HEJJAOUI, A
    CHANAL, I
    LEBEL, B
    DHIVERT, H
    MICHEL, FB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (01) : 43 - 53
  • [47] Hypochlorous Acid Versus Saline Nasal Irrigation in Allergic Rhinitis: A Multicenter, Randomized, Double-Blind, Placebo-controlled Study
    Kim, Ho Chan
    Kim, Dong-Kyu
    Kim, Ji Sun
    Lee, Ho Jun
    Bae, Mi Rye
    Choi, Woo Ri
    Jang, Yong Ju
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2022, 36 (01) : 129 - 134
  • [48] Montelukast in the treatment of spring allergic rhinitis in a large, double-blind, randomized, placebo-controlled study
    Malmstrom, K
    Hampel, FC
    Philip, G
    Malice, MP
    Reiss, TF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S157 - S157
  • [49] Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Rimmer, J.
    Peake, H. L.
    Santos, C. M. C.
    Lean, M.
    Bardin, P.
    Robson, R.
    Haumann, B.
    Loehrer, F.
    Handel, M. L.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (01): : 8 - 14
  • [50] Efficacy and safety of Phlai capsule for allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Hoang, M. P.
    Seresirikachorn, K.
    Kerr, S.
    Kanjanaumporn, J.
    Aeumjaturapat, S.
    Chusakul, S.
    Samuthpongtorn, J.
    Chitsuthipakorn, W.
    Kasemsiri, P.
    Kirtsreesakul, V.
    Prasittivatechakool, K.
    Tantilipikorn, P.
    Poachanukoon, O.
    Snidvongs, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60